Concepedia

George Hajjar

GH

Statistics

Publications

14

Citations

762

H-Index

12

Active since

1959

Affiliations

Center for Molecular Medicine and Immunology(Current)

Ottawa Hospital

University of Ottawa

George Hajjar is an author at Center for Molecular Medicine and Immunology specializing in medicine, oncology, and surgery.

Publications per year

1959–2016

14

Publications

14

Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and (111)In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphoma.

Malik E. Juweid, Edward A. Stadtmauer, George Hajjar et al. · PubMed · 1999 · 119 citations

Pharmacy, Oncology, Pharmacokinetics +17

Perioperative ischaemia in aortic surgery: combined epidural/ general anaesthesia and epidural analgesia vs general anaesthesia andiv analgesia

R. L. Garnett, Annette MacIntyre, Patrice Lindsay et al. · Canadian Journal of Anesthesia/Journal canadien d anesthésie · 1996 · 105 citations

Medicine, Perioperative Medicine, Surgery +11

Radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response?

Robert M. Sharkey, A. J. Brenner, J. D. Burton et al. · PubMed · 2003 · 92 citations

Medicine, Oncology, Pharmacology +17

Phase I/II trial of131I-MN-14 F(ab)2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma

Malik E. Juweid, George Hajjar, Lawrence C. Swayne et al. · Cancer · 1999 · 83 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Initial experience with high-dose radioimmunotherapy of metastatic medullary thyroid cancer using 131I-MN-14 F(ab)2 anti-carcinoembryonic antigen MAb and AHSCR.

Malik Juweid, George Hajjar, Rhona Stein et al. · PubMed · 2000 · 71 citations

Medicine, Nuclear Medicine, Oncology +17

1–5 of 14